In 2014, a survey by the MS Society found that one in five patients had used cannabis to help with their symptoms, including muscle spasms or stiffness (spasticity) and pain.
Multiple sclerosis (MS) is a condition that affects the brain and spinal cord, causing a range of symptoms including problems with sight, limb movement and balance.
Although it can be mild for some people, the lifelong condition can cause serious disability and the life expectancy of those living with MS is slightly reduced.
In a lot of cases, it’s possible to treat the symptoms, but as recent studies show, increasing numbers of patients have been turning to cannabinoids to help with pain and discomfort.
A main symptom of MS is muscle stiffness and spasms. CBD is known for its properties that aid the immune system, accelerate muscle recovery and help users to relax, but findings also suggest that those who have used cannabinoid products have seen a reduction in pain and improvements in spasticity and sleep.
In the UK, the cannabis plant-derived oral extract drug, Sativex, has been approved for treatment in MS-related spasticity.
Pain and discomfort
CBD is known to be an effective and natural muscle relaxant. Be helping to relieve the tension even just marginally, this can help to prevent various types of pain, including central neuropathic, which feels like pins and needles or burning, and pain from spasms.
In the last year, more than 40 per cent of people who live with MS have admitted to using cannabis products to tackle chronic pain and sleep disturbances – both of which are two common symptoms of the disease.
Also known for relieving anxiety and stress by accelerating the production of Anandamide, using cannabidiol products can help mentally and physically relax someone suffering from MS so they can settle during the day and night.
Trials have shown that taking an oral cannabis product before going to bed has helped those with MS to sleep and can stop them needing the toilet, but there isn’t convincing evidence to support using CBD to treat bladder problems.
Reduced prescription drugs
CBD is known as an effective alternative to pharmacy products as it has results to help a range of conditions, including MS, autism, Parkinson’s, PTSD, ADHD, epilepsy and neurological disorders.
Studies have found that a lot of sufferers have stopped or reduced their use of prescription medications such as Opioids and Benzodiazepines, as they’ve found cannabis to manage symptoms more effectively.
- Malta gives green light to three new cannabis clubs
- European Commission must address ‘inequality’ in access to medicinal cannabis across EU
- 1 in 8 older US adults now use cannabis products, finds study
- 3 main contributors to the entourage effect for cannabis consumers to consider
- Medical cannabis doesn’t impair cognitive function – study
- Ukraine’s medical cannabis legalisation delayed by opponents
- News4 months ago
NHS approves major clinical trial on cannabis medicines and chronic pain
- News6 months ago
UK patient secures first NHS reimbursement for cannabis flowers
- Advocacy6 months ago
Inside a UK cannabis club: changing lives, tackling stigma, building community
- News4 months ago
UK research finds GP support for cannabis as an alternative to opioids for chronic pain
- Industry4 months ago
‘Landmark’ ruling gives hope for UK CBD flower businesses
- Industry6 months ago
New report calls for overhaul of ‘discriminatory’ UK cannabis driving laws
- News4 months ago
Malta: Advocates emphasise positive effects of cannabis reform amid ‘normalisation’ concerns
- Science4 months ago
Five new cannabis studies – ALS, epilepsy, Parkinson’s, chronic pain and blood pressure